Miss in 3Q; US / higher RM costs drag down earnings
Cadila Healthcare (CDH) delivered lower-than-expected 3QFY22 earnings, weighed by lower Domestic Formulation (DF) / US / EM sales and increased...
245 Views
Event Update - ZyCoV-D vaccine approved in increasingly competitive domestic market - BUY
trial of the vaccine on 28,000 volunteers, including 1400 subjects in the age group of 12-17 age group. With favorable and acceptable safety...
114 Views
Event Update - ZyCoV-D vaccine approved in increasingly competitive domestic market - BUY
trial of the vaccine on 28,000 volunteers, including 1400 subjects in the age group of 12-17 age group. With favorable and acceptable safety...
141 Views
Cadila Health Care: Outlook Promising with Strong Pipeline
Cadila Healthcare is India's leading vertically integrated pharmaceutical company. With its presence across the value chain, it manufactures...
146 Views
Cadila Healthcare: Indian Shines but US Slowdown Persists
It has a global presence and sells its products in the US, India, Europe & emerging markets including countries in LatAm, Asia Pacific & Africa...
250 Views